A sequential procedure for monitoring clinical trials against historical controls

Statistics in Medicine

Volumn 26, Issue 7, 2007, Pages 1497-1511

  Xiong, Xiaoping ^a   Tan, Ming ^b   Boyett, James ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

Hypothesis testing; SCPRT; Sequential analysis; Survival analysis

Indexed keywords

AMIFOSTINE; CISPLATIN;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEASIBILITY STUDY; HUMAN; MATHEMATICAL ANALYSIS; MEDULLOBLASTOMA; METHODOLOGY; OTOTOXICITY; QUALITATIVE ANALYSIS; RANDOMIZATION; SAMPLE SIZE; SEQUENTIAL ANALYSIS; VALIDATION PROCESS;

AMIFOSTINE; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; HEARING LOSS; HUMANS; MEDULLOBLASTOMA; RADIATION-PROTECTIVE AGENTS; SURVIVAL ANALYSIS;

EID: 33947168719     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2635     Document Type: Article

References (17)

1. Pocock S. Randomized versus historical controls: a compromise solution. PIBiomC 1976; 9(1):245-260.
2. Farewell VT, D'Angio GJ. A simulated study of historical controls using real data. Biometrics 1981; 37(1): 169-176.
3. Gehan EA. Design of controlled clinical trials: use of historical controls. Cancer Treatment Reports 1982; 66:1089-1093.
4. Fleming TR. Historical controls, data banks, and randomized trials in clinical research: a review. Cancer Treatment Reports 1982; 66(5):1101-1105.
5. Green SG, Byar DP. Using observational data from registries to compare treatments: the fallacy of omnimetrics. Statistics in Medicine 1984; 3:361-370.
6. Makuch RW, Simon RM. Sample size considerations for non-randomized comparative studies. Journal of Clinical Epidemiology 1980; 33:175-181.
7. Dixon DO, Simon R. Sample size considerations for studies comparing survival curves using historical controls. Journal of Clinical Epidemiology 1988; 41(12):1209-1213.
8. Kepner J, Wackerly D. Some observations on the Makuch/Simon approach to sample size determination in clinical trials with historical controls. Communications in Statistics, Part B - Simulations and Computation 2001; 30(3):611-621.
9. Baker SG, Lindeman KS. The paired availability design: a proposal for evaluating epidural analgesia during labor. Statistics in Medicine 1994; 13:2269-2278.
10. Baker SG, Lindeman KS. Rethinking historical controls. Biostatistics 2002; 2(4):383-396.
11. Chang MN, Shuster JJ, Kepner JL. Group sequential designs for phase II trials with historical controls. Controlled Clinical Trials 1999; 20(5):353-364.
12. Jennison C, Turnbull B. Group-sequential analysis incorporating covariate information. Journal of the American Statistical Association 1997; 92(440):1330-1341.
13. Xiong X. A class of sequential conditional probability ratio tests. Journal of the American Statistical Association 1995; 90(432):1463-1473.
14. Xiong X, Tan M, Boyett J. Sequential conditional probability ratio tests for normalized test statistic on information time. Biometrics 2003; 59(3):624-631.
15. Xiong X, Tan M. Evaluating sequential tests for a class of stochastic processes. Computing Science and Statistics 2001; 33:30-34.
16. Kalbfeisch J, Prentice R. The Statistical Analysis of Failure Time Data (2nd edn). Wiley: Hoboken, 2002; 14-19.
17. Collett D. Modeling Survival Data in Medical Research (2nd edn). Chapman and Hall/CRC Press: Boca Raton, 2003; 299-312.